Trastuzumab and Vinorelbine in Advanced Breast Cancer
Clinical trial NCT01185509 · TERMINATED
Trial details
- NCT number
- NCT01185509
- Sponsor
- Dana-Farber Cancer Institute
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-11-01
- Primary completion
- 2017-01-01
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.